Stay updated on Lasmiditan vs Placebo in Migraine: Clinical Trial
Sign up to get notified when there's something new on the Lasmiditan vs Placebo in Migraine: Clinical Trial page.

Latest updates to the Lasmiditan vs Placebo in Migraine: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.3.3 was added to the page, and the HHS Vulnerability Disclosure link plus Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedHistory shows a new Revision: v3.3.2 added and Revision: v3.3.1 removed in the study's Record History. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.3.1 was added to the Record History and Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check55 days agoChange DetectedThe notice regarding government funding lapse and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check69 days agoChange DetectedA new version entry on 2019-12-02 was added with updated Study Status/Results and IPDSharing information. The version history now reflects the most recent changes to the trial record.SummaryDifference0.1%

- Check97 days agoChange DetectedMajor update: the page now includes a government-operating status notice and announces version v3.2.0, replacing the old v3.1.0.SummaryDifference12%

Stay in the know with updates to Lasmiditan vs Placebo in Migraine: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lasmiditan vs Placebo in Migraine: Clinical Trial page.